ARCHIVES

Study Suggests Biomarker For Resistance to Tamoxifen

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013

NCI Programs: HMO Research Network wins $16 Million Grant for Prevention Studies

July 30, 1999

ACS Cancer Response System Budget Request Total $185,140

August 9, 1985

In Brief: Mark Kochevar Named New Administrative Officer Of DCE; Thomas Necheles Dies Suddenly at 51

September 21, 1984

BRMP Investigators Find New Lung Tumor Antigen, Seek Developers

January 8, 1982

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991